Open Access
Issue
BIO Web Conf.
Volume 75, 2023
The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2023)
Article Number 05017
Number of page(s) 10
Section Big Data for Public Health Policy
DOI https://doi.org/10.1051/bioconf/20237505017
Published online 15 November 2023
  • D. Panatto, N. L. Bragazzi, E. Rizzitelli, P. Bonanni, S. Boccalini, G. Icardi, R. Gasparini, D. Amicizia, Evaluation of the economic burden of Herpes Zoster (HZ) infection: A systematic literature review, Human Vaccines & Immunotherapeutics, 11, 245-62, (2015). [CrossRef] [PubMed] [Google Scholar]
  • J. M. Weinberg, Herpes zoster: epidemiology, natural history, and common complications, Journal of the American academy of dermatology, 57, S130-S5, (2007). [CrossRef] [PubMed] [Google Scholar]
  • B. P. Yawn, D. Gilden, The global epidemiology of herpes zoster, Neurology, 81, 928-30, (2013). [CrossRef] [PubMed] [Google Scholar]
  • P. San Martin, K. Aunhachoke, M. C. F. Batac, K. Lodrono-Lim, C. Kwanthitinan, D. Santoso, T. Fonseka, M. Nguyen, A. Guzman-Holst, Systematic Literature Review of Herpes Zoster Disease Burden in Southeast Asia, Infectious diseases and therapy, 12, 1553-78, (2023). [CrossRef] [PubMed] [Google Scholar]
  • R. Harbecke, J. I. Cohen, M. N. Oxman, Herpes Zoster Vaccines, J Infect Dis, 224, S429-s42, (2021). [CrossRef] [PubMed] [Google Scholar]
  • A. L. Cunningham, M. J. Levin, Herpes zoster vaccines, The Journal of Infectious Diseases, 218, S127-S33, (2018). [CrossRef] [PubMed] [Google Scholar]
  • O. Damm, J. Witte, W. Greiner, A systematic review of herpes zoster vaccine acceptance, Value in Health, 18, A592, (2015). [CrossRef] [Google Scholar]
  • L. J. F. Rutten, X. Zhu, A. L. Leppin, J. L. Ridgeway, M. D. Swift, J. M. Griffin, J. L. St Sauver, A. Virk, R. M. Jacobson, editors. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clinic Proceedings; 2021: Elsevier. [Google Scholar]
  • K. Attwell, E. Dube, A. Gagneur, S. B. Omer, L. S. Suggs, A. Thomson, Vaccine acceptance: science, policy, and practice in a ‘post-fact’world, Vaccine, 37, 677-82, (2019). [CrossRef] [PubMed] [Google Scholar]
  • T. N. Huyen, S. Pumtong, S. Sangroongruangsri, L. Anuratpanich, Acceptability of and willingness to pay for human immunodeficiency virus vaccination: A systematic literature review, Journal of Pharmacy & Pharmacognosy Research, 10, 748-67, (2022). [CrossRef] [Google Scholar]
  • R. K. Alhassan, E. Nketiah-Amponsah, M. Immurana, A. A. Abuosi, Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana, BMC Public Health, 22, 1-14, (2022). [CrossRef] [Google Scholar]
  • B. Jiang, Q. Wang, Z. Wang, Y. Xu, T. Yang, W. Yang, M. Jia, L. Feng, Willingness to accept herpes zoster vaccines and the influencing factors in China, BMC Infectious Diseases, 22, 1-9, (2022). [CrossRef] [PubMed] [Google Scholar]
  • R. Eilers, H. De Melker, J. Veldwijk, P. Krabbe, Vaccine preferences and acceptance of older adults, Vaccine, 35, 2823-30, (2017). [CrossRef] [PubMed] [Google Scholar]
  • N. Valente, S. Lupi, A. Stefanati, M. Cova, N. Sulcaj, L. Piccinni, GPs Study Group, G. Gabutti, Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study, BMJ open, 6, e011539, (2016). [CrossRef] [PubMed] [Google Scholar]
  • O. Chayangsu, S. Jiamton, C. Leeyaphan, N. Prasertworonun, V. Omcharoen, K. Kulthanan, Willingness to pay, quality of life, and knowledge on herpes zoster among Thai patients prior zoster vaccine era, Southeast Asian J Trop Med Public Health, 47, 6, (2016). [Google Scholar]
  • J. B. Institute, Checklist for Analytical Cross Sectional Studies, (2017). [Google Scholar]
  • J. B. Institute, The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews checklist for analytical cross sectional studies, North Adelaide, Australia The Joanna Briggs Institute, (2017). [Google Scholar]
  • PRISMA, PRISMA2020 flow diagram, (2020). [Google Scholar]
  • C. Del Signore, A. Hemmendinger, N. Khanafer, J. Thierry, E. Trépo, G. Martin Gaujard, R. Chapurlat, C. Elias, P. Vanhems, Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study, Vaccine, 38, 5891-5, (2020). [CrossRef] [PubMed] [Google Scholar]
  • D. Al-Orini, A. A. Alshoshan, A. O. Almutiri, A. A. Almreef, E. S. Alrashidi, A. M. Almutiq, R. Noman, O. Al-Wutayd, Acceptability of Herpes Zoster Vaccination among Patients with Diabetes: A CrossSectional Study in Saudi Arabia, Vaccines, 11, (2023). [Google Scholar]
  • L. Kaplan-Weisman, E. Waltermaurer, C. Crump, Assessing and Improving Zoster Vaccine Uptake in a Homeless Population, Journal of community health, 43, 1019-27, (2018). [CrossRef] [PubMed] [Google Scholar]
  • N. K. Roh, Y. M. Park, H. Kang, G. S. Choi, B. J. Kim, Y. W. Lee, B. L. Lew, W. Y. Sim, Awareness, Knowledge, and Vaccine Acceptability of Herpes Zoster in Korea: A Multicenter Survey of 607 Patients, Annals of dermatology, 27, 531-8, (2015). [CrossRef] [PubMed] [Google Scholar]
  • D. M. MacDougall, B. A. Halperin, D. MacKinnonCameron, L. Li, S. A. McNeil, J. M. Langley, S. A. Halperin, The challenge of vaccinating adults: Attitudes and beliefs of the Canadian public and healthcare providers, BMJ Open, 5, (2015). [Google Scholar]
  • N. A. Baalbaki, J. P. Fava, M. Ng, E. Okorafor, A. Nawaz, W. Chiu, A. Salim, R. Cha, P. E Kilgore, A Community-Based Survey to Assess Knowledge, Attitudes, Beliefs and Practices Regarding Herpes Zoster in an Urban Setting, Infectious diseases and therapy, 8, 687-94, (2019). [CrossRef] [PubMed] [Google Scholar]
  • A. Parlato, V. R. Spica, M. Ciccozzi, F. Farchi, F. Gallè, V. Di Onofrio, E. Franco, G. Liguori, Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy, BMC Public Health, 10, (2010). [CrossRef] [Google Scholar]
  • O. S. Alhothali, A. S. Alhothali, A. A. Hanif, M. F. Bondagji, A Cross-Sectional Study of the Knowledge, Practice, and Attitude Towards Herpes Zoster Vaccination Among the General Population in the Western Region …, Cureus, (2023). [Google Scholar]
  • W. Opstelten, G. A. van Essen, E. Hak, Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly, Vaccine, 27, 192-6, (2009). [CrossRef] [PubMed] [Google Scholar]
  • A. Bayraktar-Ekincioglu, E. Kara, M. Bahap, Does information by pharmacists convince the public to get vaccinated for pneumococcal disease and herpes zoster?, Irish Journal of Medical …, (2022). [Google Scholar]
  • O. E. Akinbosoye, M. S. Taitel, J. Grana, C. Macpherson, Factors associated with Zostavax abandonment, American Journal of Pharmacy Benefits, 8, 84-9, (2016). [Google Scholar]
  • X. Lu, J. Lu, L. Zhang, K. Mei, B. Guan, Y. Lu, Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years, Expert Review of Vaccines, 20, 1147-52, (2021). [CrossRef] [PubMed] [Google Scholar]
  • P.-J. Lu, G. L. Euler, A. O. Jumaan, R. Harpaz, Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors, Vaccine, 27, 882-7, (2009). [CrossRef] [PubMed] [Google Scholar]
  • N. Kalra, T. Kalra, S. Mishra, S. Basu, N. Bhatnagar, Hesitancy for Adult Vaccines Among Healthcare Providers and their Family Members in Delhi, India: A Cross-Sectional Study, Dialogues Health, 1, 100044, (2022). [CrossRef] [Google Scholar]
  • B. P. Yawn, D. D. Merrill, S. Martinez, E. Callen, J. Cotton, D. Williams, N. Y Loskutova, Knowledge and Attitudes Concerning Herpes Zoster among People with COPD: An Interventional Survey Study, Vaccines, 10, (2022). [Google Scholar]
  • X. Lu, J. Lu, F. Zhang, A. L. Wagner, L. Zhang, K. Mei, B. Guan, Y. Lu, Low willingness to vaccinate against herpes zoster in a Chinese metropolis, Hum Vaccin Immunother, 17, 4163-70, (2021). [CrossRef] [PubMed] [Google Scholar]
  • L. A. B. Nicholls, A. J. Gallant, N. Cogan, S. Rasmussen, D. Young, L. Williams, Older adults’ vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake, Vaccine, 39, 3520-7, (2021). [CrossRef] [PubMed] [Google Scholar]
  • L. Y. Cheng, A pilot study to assess the awareness of herpes zoster and the attitudes towards herpes zoster vaccination among Chinese patients attending a government general out-patient clinic in Hong Kong, Hong Kong Practitioner, 41, (2019). [Google Scholar]
  • B. J. Patterson, K. Myers, A. Stewart, B. Mange, E. M. Hillson, C. Poulos, Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment, Expert review of vaccines, 20, 729-41, (2021). [CrossRef] [PubMed] [Google Scholar]
  • T. U. Yang, H. J. Cheong, J. Y. Song, J. Y. Noh, W. J. Kim, Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea, Hum Vaccin Immunother, 11, 719-26, (2015). [CrossRef] [PubMed] [Google Scholar]
  • K. M. Maertzdorf, M. L. Rietman, M. S. Lambooij, Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster A pre-COVID-19 exploration among the older adult …, Vaccine, (2023). [Google Scholar]
  • T. Babatope, V. Ilyenkova, D. Marais, COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria, Bull Natl Res Cent, 47, 45, (2023). [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.